Allogene Therapeutics Inc Working Capital to Net Assets Ratio
Allogene Therapeutics Inc working capital to net assets ratio. Allogene Therapeutics Inc (ALLO) has a Working Capital to Net Assets ratio of 72.6% as of September 2025. Working capital of $228.89 Million (current assets of $260.72 Million minus current liabilities of $31.83 Million) is measured against net assets of $315.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Allogene Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Allogene Therapeutics Inc (2017–2024)
Working capital to net assets ratio of Allogene Therapeutics Inc from 2017 to 2024. This chart shows how Allogene Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 72.6%, reflecting working capital of $228.89 Million against net assets of $315.33 Million USD. See operational self-sufficiency of Allogene Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Allogene Therapeutics Inc Working Capital to Net Assets Ratio by Year (2017–2024)
Allogene Therapeutics Inc working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Allogene Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Allogene Therapeutics Inc (ALLO) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 63.4% | $267.86 Million | $422.18 Million | $303.39 Million | $35.52 Million | ▼ -18.9 pp |
| 2023 | 82.4% | $422.04 Million | $512.23 Million | $459.12 Million | $37.08 Million | ▲ +11.2 pp |
| 2022 | 71.2% | $475.10 Million | $666.88 Million | $528.82 Million | $53.73 Million | ▲ +25.5 pp |
| 2021 | 45.8% | $423.42 Million | $925.20 Million | $471.32 Million | $47.91 Million | ▼ -23.8 pp |
| 2020 | 69.5% | $750.81 Million | $1.08 Billion | $845.13 Million | $94.32 Million | ▼ -11.8 pp |
| 2019 | 81.3% | $511.50 Million | $629.02 Million | $544.58 Million | $33.08 Million | ▲ +19.0 pp |
| 2018 | 62.4% | $438.52 Million | $703.16 Million | $467.98 Million | $29.46 Million | ▼ -37.6 pp |
| 2017 | 100.0% | $-2.00K | $-2.00K | $0.00 | $2.00K | — |